Advertisement
AFIB 外匯新聞
Acutus Medical Sees Q4, FY22 Revenues Well Above Estimates; Appoints Takeo Mukai As CFO
Arrhythmia management company Acutus Medical, Inc. (AFIB) announced Monday that it expects revenues for the fourth quarter in a range of approximately $4.7 million to $4.9 million, compared to $4.4 million in the prior-year quarter.
RTTNews
|
843天前
Acutus Medical Announces FDA Cleared Commercial Launch Of AcQCross Qx System
Arrhythmia management company Acutus Medical, Inc. (AFIB) announced Monday the commercial launch of an expanded suite of left-heart access products to now include the AcQCross Qx system for use with the TruSeal and FXD delivery system for the Watchman LAAC Device.
RTTNews
|
1039天前
